MACULARIS

monoclonal antibodies for therapeutic purposes, namely, monoclonal antibodies for treatment of macular degeneration or for treatment, maintaining and protecting health of the macular region; medical therapeutic agents for treatment of macular degeneration, namely, medical therapeutic agents for treatment, maintaining and protecting health of the macular region; medical therapeutic drugs for treatment of macular degeneration, namely, drugs directed against complement cascade factors and proteins, anti-inflammatories, anti-oxidants, lutein, xanthine and xanthine derivatives

Medical services, namely, ophthalmology; optometry